跳至主要内容
临床试验/NCT00974831
NCT00974831已完成2 期

Glucose Tolerance in Healthy Overweight Adults

Abbott Nutrition2 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2009年7月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
24
试验地点
2
主要终点
The primary variable is the positive area under the curve from 0 to 180 minutes for plasma glucose.

研究概览

简要总结

The primary objective is to compare the postprandial glycemic response of healthy overweight adults after consuming an amino acid drink mix versus a control drink.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Fasting blood glucose level of ≥ 70mg/dL and ≤ 125 mg/dL.
  • Subject states that he/she does not have type 1 or 2 diabetes.
  • Subject is overweight as defined as waist circumference ≥ 101 cm (40 inches) male; ≥ 88 cm (35 inches) female.
  • Subject's BMI is ≥ 25 kg/m
  • Subject's blood pressure is < 140 mm Hg systolic and < 90 mm Hg diastolic.
  • Subject is between 20 and 45 years of age, inclusive.
  • Subject is a male or a non-pregnant, non-lactating female, at least 6 weeks postpartum prior to screening visit.
  • If female is of childbearing potential, is practicing birth control
  • If subject is on a chronic medication such as a thyroid medication or hormone therapy, has been on constant dosage for at least two months prior to screening visit.

排除标准

  • Subject is eating a low carbohydrate diet such as Atkins, Zone, or South Beach diet plan.
  • Subject states that he/she has current infection, has had inpatient surgery, or corticosteroid treatment in the last 3 months or antibiotics in the last 3 weeks prior to screening visit.
  • Subject states that he/she has an active malignancy.
  • Subject states that he/she has had a significant cardiovascular event ≤ six months prior to screening visit; or stated history of congestive heart failure.
  • Subject states that he/she has end-stage organ failure or is status post organ transplant.
  • Subject states that he/she has a history of renal disease.
  • Subject states that he/she has current hepatic disease.
  • Subject states that he/she has a chronic, contagious, infectious disease, such as active tuberculosis, Hepatitis B or C, or HIV.
  • Subject has taken/is currently taking any herbals, dietary supplements, or medications during the past four weeks prior to screening visit that could profoundly affect blood glucose.
  • Subject has taken/is currently taking any herbals, dietary supplements, or medications during the past four weeks prior to screening visit to control hypertension or cholesterol.
  • Subject states that he/she has clotting or bleeding disorders.

结局指标

主要结局

The primary variable is the positive area under the curve from 0 to 180 minutes for plasma glucose.

时间窗: 0-180 minutes

次要结局

  • Plasma glucose, insulin, C-peptide, free fatty acids, and glucagon concentration data over time(0-180 minutes)

研究者

申办方类型
Industry

研究点 (2)

Loading locations...

相似试验